How Long Can We Leave Patients With Pulmonary Arterial Hypertension on Oral Drug Monotreatment?

被引：0
|
作者：
Ogawa, Aiko [1 ]
Matsubara, Hiromi [1 ]
机构：
[1] Natl Hosp Org, Dept Clin Sci, Okayama Med Ctr, Kita Ku, Okayama 7011192, Japan
来源：
CIRCULATION JOURNAL | 2012年 / 76卷 / 05期
关键词：
SILDENAFIL CITRATE; PROGNOSTIC-FACTORS; SURVIVAL; THERAPY;
D O I：
10.1253/circj.CJ-12-0341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [31] EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Karelkina, E. V.
    Goncharova, N. S.
    Simakova, M. A.
    Moiseeva, O. M.
    KARDIOLOGIYA, 2020, 60 (04) : 36 - 42
  • [32] Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment
    Gruenig, Ekkehard
    Ohnesorge, Johanna
    Benjamin, Nicola
    Burhenne, Juergen
    Enderle, Yeliz
    Egenlauf, Benjamin
    Fischer, Christine
    Harutyunova, Satenik
    Huppertz, Andrea
    Klose, Hans
    Haefeli, Walter E.
    RESPIRATION, 2017, 94 (01) : 26 - 37
  • [33] How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 23 - 32
  • [34] Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    Stiebellehner, L
    Petkov, V
    Vonbank, K
    Funk, G
    Schenk, P
    Ziesche, R
    Block, LH
    CHEST, 2003, 123 (04) : 1293 - 1295
  • [35] Long Term Outcomes Of Pulmonary Arterial Hypertension In Patients Treated With Dasatinib
    Weatherald, J.
    Chaumais, M. -C.
    Savale, L.
    Jais, X.
    Seferian, A.
    Sitbon, O.
    Simonneau, G.
    Guignabert, C.
    Humbert, M.
    Montani, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] CAN WE GENERATE SYSTEMIC ARTERIAL HYPERTENSION BY PULSATILE LVAD IN OUR PATIENTS?
    Macku, D.
    Jezek, F.
    Hunka, P.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2011, 34 (08): : 682 - 682
  • [37] Long Term Use Of Imatinib In Patients With Severe Pulmonary Arterial Hypertension
    Ghofrani, H. A.
    Morrell, N. W.
    Hoeper, M. M.
    Olschewski, H.
    Peacock, A.
    Barst, R. J.
    Shapiro, S.
    Quinn, D. A.
    Pascoe, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [38] Pulmonary Arterial Hypertension versus Pulmonary Venous Hypertension: How Much Information Can Contrast Doppler Echocardiography Provide? Reply
    Tinkel, Jodi
    Taleb, Mohammed
    Khouri, Samer
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2013, 30 (06): : 736 - 736
  • [39] Drug-associated pulmonary arterial hypertension
    McGee, Michael
    Whitehead, Nicholas
    Martin, Jennifer
    Collins, Nicholas
    CLINICAL TOXICOLOGY, 2018, 56 (09) : 801 - 809
  • [40] New drug approved for pulmonary arterial hypertension
    Young, Donna
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (15) : 1562 - 1562
12345